{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:11:27Z","timestamp":1793643087305,"version":"4.5.1"},"reference-count":105,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["1R21MH073624"],"award-info":[{"award-number":["1R21MH073624"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS073884"],"award-info":[{"award-number":["1R01NS073884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["RIAQ094"],"award-info":[{"award-number":["RIAQ094"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["AA11034"],"award-info":[{"award-number":["AA11034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["R41 MD012318\/MD\/NIMHD NIH HHS\/United States"],"award-info":[{"award-number":["R41 MD012318\/MD\/NIMHD NIH HHS\/United States"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Institutes of Health","doi-asserted-by":"publisher","award":["R01HD70888-01A1"],"award-info":[{"award-number":["R01HD70888-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPSP"],"published-print":{"date-parts":[[2021,6,8]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Polymorphic gene variants, particularly the genetic determinants of low dopamine function (hypodopaminergia), are known to associate with Substance Use Disorder (SUD) and a predisposition to PTSD. Addiction research and molecular genetic applied technologies supported by the National Institutes of Health (NIH) have revealed the complex functions of brain reward circuitry and its crucial role in addiction and PTSD symptomatology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion:<\/jats:title><jats:p>It is noteworthy that Israeli researchers compared mice with a normal immune system with mice lacking adaptive immunity and found that the incidence of PTSD increased several-fold. It is well established that raising endorphinergic function increases immune response significantly. Along these lines, Blum\u2019s work has shown that D-Phenylalanine (DPA), an enkephalinase inhibitor, increases brain endorphins in animal models and reduces stress in humans. Enkephalinase inhibition with DPA treats Post Traumatic Stress Disorder (PTSD) by restoring endorphin function. The Genetic Addiction Risk Severity (GARS) can characterize relevant phenotypes, genetic risk for stress vulnerability vs. resilience. GARS could be used to pre-test military enlistees for adaptive immunity or as part of PTSD management with customized neuronutrient supplementation upon return from deployment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Based on GARS values, with particular emphasis on enhancing immunological function, pro-dopamine regulation may restore dopamine homeostasis. Recognition of the immune system as a \u201csixth sense\u201d and assisting adaptive immunity with Precision Behavioral Management (PBM), accompanied by other supportive interventions and therapies, may shift the paradigm in treating stress disorders.<\/jats:p><\/jats:sec>","DOI":"10.2174\/2211556009999210104221215","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T09:40:55Z","timestamp":1609839655000},"page":"86-97","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic"],"prefix":"10.2174","volume":"10","author":[{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[{"name":"Western University Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Modestino","sequence":"additional","affiliation":[{"name":"Department of Psychology, Curry College, Milton, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baron","sequence":"additional","affiliation":[{"name":"Western University Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Brewer","sequence":"additional","affiliation":[{"name":"Division of Precision Behavioral Management, Geneus Health, San Antonio, TX, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis","family":"Thanos","sequence":"additional","affiliation":[{"name":"Behavioral Neuropharmacology & Neuroimaging Laboratory on Addiction, Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Elman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard School of Medicine, Cambridge MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra D.","family":"Badgaiyan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. William","family":"Downs","sequence":"additional","affiliation":[{"name":"Division of Nutrigenomics, Victory Nutrition International, Lederoch, PA., United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Bagchi","sequence":"additional","affiliation":[{"name":"Division of Nutrigenomics, Victory Nutrition International, Lederoch, PA., United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Center for Psychiatric Medicine, Lawrence MA., United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Bowirrat","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Genetics, Interdisciplinary Center Herzliya, Herzliya, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Kenison","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Tulane School of Medicine, New Orleans, LA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University, School of Medicine, St. Louis, MO., United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Blum K.","year":"2017","unstructured":"Blum K.; Reward deficiency syndromeThe SAGE encyclopedia of abnormal and clinical psychology University of Pennsylvania School of Medicine 2017","journal-title":"Reward deficiency syndromeThe SAGE encyclopedia of abnormal and clinical psychology University of Pennsylvania School of Medicine"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/157015910793358123","volume":"8","author":"Bowirrat A.","year":"2010","unstructured":"Bowirrat A.; Chen T.J.; Blum K.; Neuro-psychopharmacogenetics and neurological antecedents of posttraumatic stress disorder: unlocking the mysteries of resilience and vulnerability. Curr Neuropharmacol 2010,8(4),335-358","journal-title":"Curr Neuropharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","volume":"89","author":"Elman I.","year":"2016","unstructured":"Elman I.; Borsook D.; Common brain mechanisms of chronic pain and addiction. Neuron 2016,89(1),11-36","journal-title":"Neuron"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1037\/14090-000","author":"Jellinek E.","year":"1960","unstructured":"Jellinek E.; The disease concept of alcoholismItaly: New Heaven: College and University Press 1960","journal-title":"The disease concept of alcoholismItaly: New Heaven: College and University Press"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1126\/science.169.3950.1105","volume":"169","author":"Davis V.E.","year":"1970","unstructured":"Davis V.E.; Walsh M.J.; Alcohol addiction and tetrahydropapaveroline. Science 1970,169(3950),1105-1106","journal-title":"Science"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1530-0277.1978.tb04713.x","volume":"2","author":"Hamilton M.G.","year":"1978","unstructured":"Hamilton M.G.; Blum K.; Hirst M.; Identification of an isoquinoline alkaloid after chronic exposure to ethanol. Alcohol Clin Exp Res 1978,2(2),133-137","journal-title":"Alcohol Clin Exp Res"},{"key":"ref=7","first-page":"299","volume":"3","author":"Collins M.A.","year":"1982","unstructured":"Collins M.A.; Kahn A.J.; Attraction to ethanol solutions in mice: induction by a tetrahydroisoquinoline derivative of L-DOPA. Subst Alcohol Actions Misuse 1982,3(5),299-302","journal-title":"Subst Alcohol Actions Misuse"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.167.3926.1749","volume":"167","author":"Cohen G.","year":"1970","unstructured":"Cohen G.; Collins M.; Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism. Science 1970,167(3926),1749-1751","journal-title":"Science"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1530-0277.1978.tb04710.x","volume":"2","author":"Blum K.","year":"1978","unstructured":"Blum K.; Hamilton M.G.; Hirst M.; Wallace J.E.; Putative role of isoquinoline alkaloids in alcoholism: a link to opiates. Alcohol Clin Exp Res 1978,2(2),113-120","journal-title":"Alcohol Clin Exp Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/014107689608900711","volume":"89","author":"Blum K.","year":"1996","unstructured":"Blum K.; Sheridan P.J.; Wood R.C.; The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 1996,89(7),396-400","journal-title":"J R Soc Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.v61n0106","volume":"61","author":"Brady K.T.","year":"2000","unstructured":"Brady K.T.; Killeen T.K.; Brewerton T.; Lucerini S.; Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry 2000,61(Suppl. 7),22-32","journal-title":"J Clin Psychiatry"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/02791072.2014.977501","volume":"47","author":"Saunders E.C.","year":"2015","unstructured":"Saunders E.C.; Lambert-Harris C.; McGovern M.P.; Meier A.; Xie H.; The prevalence of posttraumatic stress disorder symptoms among addiction treatment patients with cocaine use disorders. J Psychoactive Drugs 2015,47(1),42-50","journal-title":"J Psychoactive Drugs"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(85)92448-1","volume":"1","author":"Dackis C.A.","year":"1985","unstructured":"Dackis C.A.; Gold M.S.; Bromocriptine as treatment of cocaine abuse. Lancet 1985,1(8438),1151-1152","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0376-8716(93)90113-5","volume":"33","author":"Noble E.P.","year":"1993","unstructured":"Noble E.P.; Blum K.; Khalsa M.E.; Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993,33(3),271-285","journal-title":"Drug Alcohol Depend"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-1781(87)90086-2","volume":"20","author":"Dackis C.A.","year":"1987","unstructured":"Dackis C.A.; Gold M.S.; Sweeney D.R.; Byron J.P.; Climko R.; Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987,20(4),261-264","journal-title":"Psychiatry Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nm0495-337","volume":"1","author":"Lawford B.R.","year":"1995","unstructured":"Lawford B.R.; Young R.M.; Rowell J.A.; Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele. Nat Med 1995,1(4),337-341","journal-title":"Nat Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.1990.03440150063027","volume":"263","author":"Blum K.","year":"1990","unstructured":"Blum K.; Noble E.P.; Sheridan P.J.; Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990,263(15),2055-2060","journal-title":"JAMA"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jinsphys.2010.03.014","volume":"56","author":"Bogomolova E.V.","year":"2010","unstructured":"Bogomolova E.V.; Rauschenbach I.Y.; Adonyeva N.V.; Alekseev A.A.; Faddeeva N.V.; Gruntenko N.E.; Dopamine down-regulates activity of alkaline phosphatase in Drosophila: the role of D2-like receptors. J Insect Physiol 2010,56(9),1155-1159","journal-title":"J Insect Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/0028-3908(87)90008-6","volume":"26","author":"Rouillard C.","year":"1987","unstructured":"Rouillard C.; B\u00e9dard P.J.; Falardeau P.; Dipaolo T.; Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology 1987,26(11),1601-1606","journal-title":"Neuropharmacology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1742-4682-5-24","volume":"5","author":"Blum K.","year":"2008","unstructured":"Blum K.; Chen A.L.; Chen T.J.; Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 2008,5,24","journal-title":"Theor Biol Med Model"},{"key":"ref=21","first-page":"139","volume":"3","author":"Blum K.","year":"2012","unstructured":"Blum K.; Oscar-Berman M.; Stuller E.; Neurogenetics and nutrigenomics of neuro-nutrient therapy for reward deficiency syndrome (rds): clinical ramifications as a function of molecular neurobiological mechanisms. J Addict Res Ther 2012,3(5),139","journal-title":"J Addict Res Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.lfs.2004.10.061","volume":"77","author":"Thanos P.K.","year":"2005","unstructured":"Thanos P.K.; Rivera S.N.; Weaver K.; Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci 2005,77(2),130-139","journal-title":"Life Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/syn.20523","volume":"62","author":"Thanos P.K.","year":"2008","unstructured":"Thanos P.K.; Michaelides M.; Umegaki H.; Volkow N.D.; D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 2008,62(7),481-486","journal-title":"Synapse"},{"key":"ref=24","first-page":"1006","volume":"1","author":"Blum K.","year":"2016","unstructured":"Blum K.; Febo M.; Badgaiyan R.D.; Fifty years in the development of a glutaminergic-dopaminergic optimization complex (KB220) to balance brain reward circuitry in reward deficiency syndrome: a pictorial. Austin Addict Sci 2016,1(2),1006","journal-title":"Austin Addict Sci"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174774","volume":"12","author":"Febo M.","year":"2017","unstructured":"Febo M.; Blum K.; Badgaiyan R.D.; Enhanced functional connectivity and volume between cognitive and reward centers of na\u00efve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS One Apr 26;2017,12(4)","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/00325481.2015.994879","volume":"127","author":"Blum K.","year":"2015","unstructured":"Blum K.; Liu Y.; Wang W.; rsfMRI effects of KB220Z\u2122 on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgrad Med 2015,127(2),232-241","journal-title":"Postgrad Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"51651","DOI":"10.3791\/51651","author":"Philip N.S.","year":"2014","unstructured":"Philip N.S.; Carpenter S.L.; Sweet L.H.; Developing neuroimaging phenotypes of the default mode network in PTSD: integrating the resting state, working memory, and structural connectivity. J Vis Exp Jul 1;2014(89),51651","journal-title":"J Vis Exp"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2017.05.008","volume":"266","author":"O\u2019Doherty D.C.M.","year":"2017","unstructured":"O\u2019Doherty D.C.M.; Tickell A.; Ryder W.; Frontal and subcortical grey matter reductions in PTSD. Psychiatry Res Neuroimaging 2017,266,1-9","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2015.01.002","volume":"232","author":"O\u2019Doherty D.C.","year":"2015","unstructured":"O\u2019Doherty D.C.; Chitty K.M.; Saddiqui S.; Bennett M.R.; Lagopoulos J.; A systematic review and meta-analysis of magnetic resonance imaging measurement of structural volumes in posttraumatic stress disorder. Psychiatry Res 2015,232(1),1-33","journal-title":"Psychiatry Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.biopsych.2017.09.006","volume":"83","author":"Logue M.W.","year":"2018","unstructured":"Logue M.W.; van Rooij S.J.H.; Dennis E.L.; Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study: subcortical volumetry results from posttraumatic stress disorder consortia. Biol Psychiatry 2018,83(3),244-253","journal-title":"Biol Psychiatry"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2470547017724069","volume":"1","author":"Akiki T.J.","year":"2017","unstructured":"Akiki T.J.; Averill C.L.; Wrocklage K.M.; The Association of PTSD Symptom Severity with Localized Hippocampus and Amygdala Abnormalities. Chronic Stress (Thousand Oaks) 2017,1,1","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1080\/02699052.2018.1492741","volume":"32","author":"Martindale S.L.","year":"2018","unstructured":"Martindale S.L.; Rowland J.A.; Shura R.D.; Taber K.H.; Longitudinal changes in neuroimaging and neuropsychiatric status of post-deployment veterans: a CENC pilot study. Brain Inj 2018,32(10),1208-1216","journal-title":"Brain Inj"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2470547017724714","volume":"1","author":"Averill L.A.","year":"2017","unstructured":"Averill L.A.; Abdallah C.G.; Pietrzak R.H.; Combat exposure severity is associated with reduced cortical thickness in combat veterans: a preliminary report. Chronic Stress (Thousand Oaks) 2017,1,1","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"15508","DOI":"10.1073\/pnas.1206330109","volume":"109","author":"van Wingen G.A.","year":"2012","unstructured":"van Wingen G.A.; Geuze E.; Caan M.W.; Persistent and reversible consequences of combat stress on the mesofrontal circuit and cognition. Proc Natl Acad Sci USA 2012,109(38),15508-15513","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.956","volume":"8","author":"Butler O.","year":"2018","unstructured":"Butler O.; Willmund G.; Gleich T.; Gallinat J.; K\u00fchn S.; Zimmermann P.; Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav 2018,8(5)","journal-title":"Brain Behav"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/138161212798919110","volume":"18","author":"Blum K.","year":"2012","unstructured":"Blum K.; Gardner E.; Oscar-Berman M.; Gold M.; \u201cLiking\u201d and \u201cwanting\u201d linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des 2012,18(1),113-118","journal-title":"Curr Pharm Des"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7412.1000116","volume":"3","author":"Blum K.","year":"2012","unstructured":"Blum K.; Giordano J.; Oscar-Berman M.; Bowirrat A.; Simpatico T.; Barh D.; Diagnosis and healing in veterans suspected of suffering from post-traumatic stress disorder (ptsd) using reward gene testing and reward circuitry natural dopaminergic activation. J Genet Syndr Gene Ther 2012,3(3)","journal-title":"J Genet Syndr Gene Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrn.2017.39","volume":"18","author":"Filiano A.J.","year":"2017","unstructured":"Filiano A.J.; Gadani S.P.; Kipnis J.; How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci 2017,18(6),375-384","journal-title":"Nat Rev Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/4734","volume":"5","author":"Moalem G.","year":"1999","unstructured":"Moalem G.; Leibowitz-Amit R.; Yoles E.; Mor F.; Cohen I.R.; Schwartz M.; Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999,5(1),49-55","journal-title":"Nat Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","volume":"97","author":"Kipnis J.","year":"2000","unstructured":"Kipnis J.; Yoles E.; Porat Z.; T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci USA 2000,97(13),7446-7451","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1523\/JNEUROSCI.21-13-04564.2001","volume":"21","author":"Kipnis J.","year":"2001","unstructured":"Kipnis J.; Yoles E.; Schori H.; Hauben E.; Shaked I.; Schwartz M.; Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci 2001,21(13),4564-4571","journal-title":"J Neurosci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1523\/JNEUROSCI.20-17-06421.2000","volume":"20","author":"Hauben E.","year":"2000","unstructured":"Hauben E.; Butovsky O.; Nevo U.; Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 2000,20(17),6421-6430","journal-title":"J Neurosci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1523\/JNEUROSCI.21-11-03740.2001","volume":"21","author":"Yoles E.","year":"2001","unstructured":"Yoles E.; Hauben E.; Palgi O.; Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 2001,21(11),3740-3748","journal-title":"J Neurosci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1073\/pnas.0402268101","volume":"101","author":"Kipnis J.","year":"2004","unstructured":"Kipnis J.; Cohen H.; Cardon M.; Ziv Y.; Schwartz M.; T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci USA 2004,101(21),8180-8185","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbi.2007.12.008","volume":"22","author":"Brynskikh A.","year":"2008","unstructured":"Brynskikh A.; Warren T.; Zhu J.; Kipnis J.; Adaptive immunity affects learning behavior in mice. Brain Behav Immun 2008,22(6),861-869","journal-title":"Brain Behav Immun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbi.2013.08.013","volume":"35","author":"Radjavi A.","year":"2014","unstructured":"Radjavi A.; Smirnov I.; Kipnis J.; Brain antigen-reactive CD4+ T cells are sufficient to support learning behavior in mice with limited T cell repertoire. Brain Behav Immun 2014,35,58-63","journal-title":"Brain Behav Immun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"Filiano A.J.","year":"2016","unstructured":"Filiano A.J.; Xu Y.; Tustison N.J.; Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour. Nature 2016,535(7612),425-429","journal-title":"Nature"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","volume":"3","author":"Moy S.S.","year":"2004","unstructured":"Moy S.S.; Nadler J.J.; Perez A.; Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004,3(5),287-302","journal-title":"Genes Brain Behav"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/neu.20249","volume":"66","author":"Cohen H.","year":"2006","unstructured":"Cohen H.; Ziv Y.; Cardon M.; Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol 2006,66(6),552-563","journal-title":"J Neurobiol"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.54","volume":"3","author":"Rattazzi L.","year":"2013","unstructured":"Rattazzi L.; Piras G.; Ono M.; Deacon R.; Pariante C.M.; D\u2019Acquisto F.; CD4 but not CD8 T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice. Transl Psychiatry 2013,3(7)","journal-title":"Transl Psychiatry"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1084\/jem.20180199","volume":"216","author":"Norris G.T.","year":"2019","unstructured":"Norris G.T.; Kipnis J.; Immune cells and CNS physiology: microglia and beyond. J Exp Med 2019,216(1),60-70","journal-title":"J Exp Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"Louveau A.","year":"2018","unstructured":"Louveau A.; Herz J.; Alme M.N.; CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 2018,21(10),1380-1391","journal-title":"Nat Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.50","volume":"121","author":"Louveau A.","year":"2018","unstructured":"Louveau A.; Filiano A.J.; Kipnis J.; Meningeal whole mount preparation and characterization of neural cells by flow cytometry. Curr Protoc Immunol 2018,121(1)","journal-title":"Curr Protoc Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"Mrdjen D.","year":"2018","unstructured":"Mrdjen D.; Pavlovic A.; Hartmann F.J.; High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 2018,48(2),380-395.e6","journal-title":"Immunity"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"Hart B.L.","year":"1988","unstructured":"Hart B.L.; Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988,12(2),123-137","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=56","first-page":"293","volume":"34","author":"Starkman B.G.","year":"2012","unstructured":"Starkman B.G.; Sakharkar A.J.; Pandey S.C.; Epigenetics-beyond the genome in alcoholism. Alcohol Res 2012,34(3),293-305","journal-title":"Alcohol Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1420-9101.2011.02425.x","volume":"25","author":"Bos N.","year":"2012","unstructured":"Bos N.; Lef\u00e8vre T.; Jensen A.B.; d\u2019Ettorre P.; Sick ants become unsociable. J Evol Biol 2012,25(2),342-351","journal-title":"J Evol Biol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fphys.2016.00261","volume":"7","author":"Kazlauskas N.","year":"2016","unstructured":"Kazlauskas N.; Klappenbach M.; Depino A.M.; Locatelli F.F.; Sickness behavior in honey bees. Front Physiol 2016,7,261","journal-title":"Front Physiol"},{"key":"ref=59","volume":"3","author":"Blum K.","year":"2012","unstructured":"Blum K.; Oscar-Berman M.; Bowirrat A.; Neuropsychiatric genetics of happiness, friendships, and politics: hypothesizing homophily (\u201cbirds of a feather flock together\u201d) as a function of reward gene polymorphisms. J Genet Syndr Gene Ther 2012,3(112)","journal-title":"J Genet Syndr Gene Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0006-3223(95)00519-6","volume":"40","author":"Comings D.E.","year":"1996","unstructured":"Comings D.E.; Muhleman D.; Gysin R.; Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol Psychiatry 1996,40(5),368-372","journal-title":"Biol Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.18","volume":"7","author":"Petrulli J.R.","year":"2017","unstructured":"Petrulli J.R.; Kalish B.; Nabulsi N.B.; Huang Y.; Hannestad J.; Morris E.D.; Systemic inflammation enhances stimulant-induced striatal dopamine elevation. Transl Psychiatry 2017,7(3)","journal-title":"Transl Psychiatry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/270618a0","volume":"270","author":"Rossier J.","year":"1977","unstructured":"Rossier J.; French E.D.; Rivier C.; Ling N.; Guillemin R.; Bloom F.E.; Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature 1977,270(5638),618-620","journal-title":"Nature"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0196-9781(81)80121-0","volume":"2","author":"Akil H.","year":"1981","unstructured":"Akil H.; Young E.; Watson S.J.; Coy D.H.; Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins. Peptides 1981,2(3),289-292","journal-title":"Peptides"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.123.3.1068","volume":"1233","author":"Wybran J.","year":"1979","unstructured":"Wybran J.; Appelboom T.; Famaey J.P.; Govaerts A.; Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 1979,1233,1068-1070","journal-title":"J Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0192-0561(83)90020-6","volume":"5","author":"Plotnikoff N.P.","year":"1983","unstructured":"Plotnikoff N.P.; Miller G.C.; Enkephalins as immunomodulators. Int J Immunopharmacol 1983,5(5),437-441","journal-title":"Int J Immunopharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1073\/pnas.79.13.4226","volume":"79","author":"Gilman S.C.","year":"1982","unstructured":"Gilman S.C.; Schwartz J.M.; Milner R.J.; Bloom F.E.; Feldman J.D.; beta-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci USA 1982,79(13),4226-4230","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0192-0561(86)90130-X","volume":"8","author":"McCain H.W.","year":"1986","unstructured":"McCain H.W.; Lamster I.B.; Bilotta J.; Modulation of human T-cell suppressor activity by beta endorphin and glycyl-L-glutamine. Int J Immunopharmacol 1986,8(4),443-446","journal-title":"Int J Immunopharmacol"},{"key":"ref=68","first-page":"92","volume":"44","author":"Wybran J.","year":"1985","unstructured":"Wybran J.; Enkephalins and endorphins as modifiers of the immune system: present and future. Fed Proc 1985,44(1 Pt 1),92-94","journal-title":"Fed Proc"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1073\/pnas.79.13.4171","volume":"79","author":"Johnson H.M.","year":"1982","unstructured":"Johnson H.M.; Smith E.M.; Torres B.A.; Blalock J.E.; Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA 1982,79(13),4171-4174","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2265.1981.tb00668.x","volume":"15","author":"Smith R.","year":"1981","unstructured":"Smith R.; Grossman A.; Gaillard R.; Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clin Endocrinol 1981,15(3),291-300","journal-title":"Clin Endocrinol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0091-3057(88)90290-0","volume":"29","author":"Vaswani K.K.","year":"1988","unstructured":"Vaswani K.K.; Richard C.W.; Tejwani G.A.; Cold swim stress-induced changes in the levels of opioid peptides in the rat CNS and peripheral tissues. Pharmacol Biochem Behav 1988,29(1),163-168","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/321881a0","volume":"321","author":"Smith E.M.","year":"1986","unstructured":"Smith E.M.; Morrill A.C.; Meyer W.J.; Blalock J.E.; Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986,321(6073),881-882","journal-title":"Nature"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15690\/vramn.v67i5.275","author":"Che\u012ddo M.A.","year":"2012","unstructured":"Che\u012ddo M.A.; Gevorgian M.M.; Role of dopamine D1- and D2-receptors in the delta1-opioidergic immunostimulationVestn Ross Akad Med Nauk 2012(5),55-57","journal-title":"Role of dopamine D1- and D2-receptors in the delta1-opioidergic immunostimulationVestn Ross Akad Med Nauk"},{"key":"ref=74","first-page":"385","volume":"84","author":"Che\u012ddo M.A.","year":"1998","unstructured":"Che\u012ddo M.A.; Idova G.V.; Effect of opioid peptides on immunomodulation Ross Fiziol Zh Im I M Sechenova 1998,84(4),385-390","journal-title":"Effect of opioid peptides on immunomodulation Ross Fiziol Zh Im I M Sechenova"},{"key":"ref=75","first-page":"47","volume":"65","author":"Williamson S.A.","year":"1988","unstructured":"Williamson S.A.; Knight R.A.; Lightman S.L.; Hobbs J.R.; Effects of beta endorphin on specific immune responses in man. Immunology 1988,65(1),47-51","journal-title":"Immunology"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3727\/036012982816952099","volume":"3","author":"Ehrenpreis S.","year":"1982","unstructured":"Ehrenpreis S.; D-phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application. Subst Alcohol Actions Misuse 1982,3(4),231-239","journal-title":"Subst Alcohol Actions Misuse"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/138945008785909356","volume":"9","author":"Thanawala V.","year":"2008","unstructured":"Thanawala V.; Kadam V.J.; Ghosh R.; Enkephalinase inhibitors: potential agents for the management of pain. Curr Drug Targets 2008,9(10),887-894","journal-title":"Curr Drug Targets"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3727\/036012982816952099","volume":"7","author":"Ehrenpreis S.","year":"1982","unstructured":"Ehrenpreis S.; D-phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application. Acupunct Electrother Res 1982,7(2-3),157-172","journal-title":"Acupunct Electrother Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.biopha.2017.02.042","volume":"89","author":"Nagarjun S.","year":"2017","unstructured":"Nagarjun S.; Dhadde S.B.; Veerapur V.P.; Thippeswamy B.S.; Chandakavathe B.N.; Ameliorative effect of chromium-d-phenylalanine complex on indomethacin-induced inflammatory bowel disease in rats. Biomed Pharmacother 2017,89,1061-1066","journal-title":"Biomed Pharmacother"},{"key":"ref=80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174774","volume":"12","author":"Febo M.","year":"2017","unstructured":"Febo M.; Blum K.; Badgaiyan R.D.; Enhanced functional connectivity and volume between cognitive and reward centers of na\u00efve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS One 2017,12(4)","journal-title":"PLoS One"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","volume":"48","author":"Noble E.P.","year":"1991","unstructured":"Noble E.P.; Blum K.; Ritchie T.; Montgomery A.; Sheridan P.J.; Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991,48(7),648-654","journal-title":"Arch Gen Psychiatry"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.psyneuen.2016.11.034","volume":"76","author":"Payer D.","year":"2017","unstructured":"Payer D.; Williams B.; Mansouri E.; Corticotropin-releasing hormone and dopamine release in healthy individuals. Psychoneuroendocrinology 2017,76,192-196","journal-title":"Psychoneuroendocrinology"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neubiorev.2011.04.012","volume":"36","author":"Cabib S.","year":"2012","unstructured":"Cabib S.; Puglisi-Allegra S.; The mesoaccumbens dopamine in coping with stress. Neurosci Biobehav Rev 2012,36(1),79-89","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/syn.20034","volume":"53","author":"Pan W.H.","year":"2004","unstructured":"Pan W.H.; Yang S.Y.; Lin S.K.; Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 2004,53(1),44-52","journal-title":"Synapse"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00127-004-0810-0","volume":"39","author":"Roy-Byrne P.","year":"2004","unstructured":"Roy-Byrne P.; Arguelles L.; Vitek M.E.; Persistence and change of PTSD symptomatology-a longitudinal co-twin control analysis of the Vietnam Era Twin Registry. Soc Psychiatry Psychiatr Epidemiol 2004,39(9),681-685","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref=86","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109667","volume":"94","author":"Cabana-Dom\u00ednguez J.","year":"2019","unstructured":"Cabana-Dom\u00ednguez J.; Shivalikanjli A.; Fern\u00e0ndez-Castillo N.; Cormand B.; Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions. Prog Neuropsychopharmacol Biol Psychiatry 2019,94","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/npp.2013.352","volume":"39","author":"Szutorisz H.","year":"2014","unstructured":"Szutorisz H.; DiNieri J.A.; Sweet E.; Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology 2014,39(6),1315-1323","journal-title":"Neuropsychopharmacology"},{"key":"ref=88","first-page":"373","volume":"38","author":"Aux\u00e9m\u00e9ry Y.","year":"2012","unstructured":"Aux\u00e9m\u00e9ry Y.; Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context Encephale 2012,38(5),373-380","journal-title":"Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context Encephale"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpsyt.2018.00170","volume":"9","author":"Zhang K.","year":"2018","unstructured":"Zhang K.; Wang L.; Cao C.; A DRD2\/ANNK1-COMT interaction, consisting of functional variants, confers risk of post-traumatic stress disorder in traumatized chinese. Front Psychiatry 2018,9,170","journal-title":"Front Psychiatry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.janxdis.2018.08.001","volume":"59","author":"Brown L.A.","year":"2018","unstructured":"Brown L.A.; Gallagher T.; Petersen J.; Benhamou K.; Foa E.B.; Asnaani A.; Does CBT for anxiety-related disorders alter suicidal ideation? Findings from a naturalistic sample. J Anxiety Disord 2018,59,10-16","journal-title":"J Anxiety Disord"},{"key":"ref=91","author":"Wildlife U.S.F.","year":"2019","unstructured":"Wildlife U.S.F.; FWS Critical Incident Stress Management Handbook 2019","journal-title":"FWS Critical Incident Stress Management Handbook"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3399\/bjgp12X653516","volume":"62","author":"Smith B.H.","year":"2012","unstructured":"Smith B.H.; Higgins C.; Baldacchino A.; Kidd B.; Bannister J.; Substance misuse of gabapentin. J R Coll Gen Pract 2012,62(601),406-407","journal-title":"J R Coll Gen Pract"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1556\/2006.4.2015.008","volume":"4","author":"McLaughlin T.","year":"2015","unstructured":"McLaughlin T.; Blum K.; Oscar-Berman M.; Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy. J Behav Addict 2015,4(2),106-115","journal-title":"J Behav Addict"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.17756\/jrds.2015-006","volume":"1","author":"McLaughlin T.","year":"2015","unstructured":"McLaughlin T.; Blum K.; Oscar-Berman M.; Using the Neuroadaptagen KB200z\u2122 to ameliorate terrifying, lucid nightmares in RDS patients: the role of enhanced, brain-reward, functional connectivity and dopaminergic homeostasis. J Reward Defic Syndr 2015,1(1),24-35","journal-title":"J Reward Defic Syndr"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.17756\/jrdsas.2016-022","volume":"2","author":"McLaughlin T.","year":"2016","unstructured":"McLaughlin T.; Febo M.; Badgaiyan R.D.; KB220Z\u2122 a pro-dopamine regulator associated with the protracted, alleviation of terrifying lucid dreams. can we infer neuroplasticity-induced changes in the reward circuit? J Reward Defic Syndr Addict Sci 2016,2(1),3-13","journal-title":"J Reward Defic Syndr Addict Sci"},{"key":"ref=96","first-page":"244","volume":"1","author":"Maxwell J.","year":"2014","unstructured":"Maxwell J.; Ethical, legal, social, and policy issues in the use of genomic technology by the US military. J Biosci 2014,1(3),244-280","journal-title":"J Biosci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jlb\/lsu030","volume":"2","author":"Evans N.G.","year":"2014","unstructured":"Evans N.G.; Moreno J.D.; Yesterday\u2019s war; tomorrow\u2019s technology: peer commentary on \u2018Ethical, legal, social and policy issues in the use of genomic technologies by the US military\u2019. J Law Biosci 2014,2(1),79-84","journal-title":"J Law Biosci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jlb\/lsv006","volume":"2","year":"2015","unstructured":"Savulescu J. Science wars-How much risk should soldiers be exposed to in military experimentation? J Law Biosci 2015,2(1),99-104","journal-title":"J Law Biosci"},{"key":"ref=99","first-page":"667","volume":"86","author":"Baumann T.K.","year":"2001","unstructured":"Baumann T.K.; Proxy consent and a national DNA databank: an unethical and discriminatory combination. Iowa Law Rev 2001,86(2),667-701","journal-title":"Iowa Law Rev"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41436-020-0928-9","volume":"22","author":"Pereira S.","year":"2020","unstructured":"Pereira S.; Hsu R.L.; Islam R.; MilSeq Project. Airmen and health-care providers\u2019 attitudes toward the use of genomic sequencing in the US Air Force: findings from the MilSeq Project. Genet Med 2020,22(12),2003-2010","journal-title":"Genet Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fpsyt.2018.00548","volume":"9","author":"Blum K.","year":"2018","unstructured":"Blum K.; Gondr\u00e9-Lewis M.C.; Baron D.; Introducing precision addiction management of reward deficiency syndrome, the construct that underpins all addictive behaviors. Front Psychiatry 2018,9,548","journal-title":"Front Psychiatry"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"19111","DOI":"10.18632\/oncotarget.8088","volume":"7","author":"Thanos P.K.","year":"2016","unstructured":"Thanos P.K.; Hamilton J.; O\u2019Rourke J.R.; Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. Oncotarget 2016,7(15),19111-19123","journal-title":"Oncotarget"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3810\/pgm.2010.11.2237","volume":"122","author":"Blum K.","year":"2010","unstructured":"Blum K.; Chen T.J.; Morse S.; Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D agonist therapy: part 2. Postgrad Med 2010,122(6),214-226","journal-title":"Postgrad Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0926-6410(01)00106-9","volume":"13","author":"Kjaer T.W.","year":"2002","unstructured":"Kjaer T.W.; Bertelsen C.; Piccini P.; Brooks D.; Alving J.; Lou H.C.; Increased dopamine tone during meditation-induced change of consciousness. Brain Res Cogn Brain Res 2002,13(2),255-259","journal-title":"Brain Res Cogn Brain Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neubiorev.2016.05.033","volume":"68","author":"Borsook D.","year":"2016","unstructured":"Borsook D.; Linnman C.; Faria V.; Strassman A.M.; Becerra L.; Elman I.; Reward deficiency and anti-reward in pain chronification. Neurosci Biobehav Rev 2016,68,282-297","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Current Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/189912","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189912\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/189912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T22:12:19Z","timestamp":1697494339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189912\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211556009999210104221215","relation":{},"ISSN":["2211-5560"],"issn-type":[{"value":"2211-5560","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}